EVELO BIOSCIENCES, INC. : Notice of Delisting or Failure to

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule
or Standard; Transfer of Listing.

On April 25, 2023, Evelo Biosciences, Inc. received a letter
from the Listing... | May 1, 2023

Related Keywords

United States , , Exchange Commission , Listing Qualifications Department Of Nasdaq , Nasdaq Stock Market , Evelo Biosciences Inc , Company Common Stock , Nasdaq Listing Qualifications Panel , Listing Qualifications Department , Nasdaq , Continued Listing Rule , Minimum Value , Nasdaq Global Select Market , Nasdaq Listing Rule , Market Value , Listed Securities , Qualifications Department , Publicly Held Shares , Common Stock , Nasdaq Global Select , Minimum Market Value , Listed Securities Requirement , Publicly Held Shares Requirement , Listing Qualifications , Nasdaq Capital Market , Current Report , Private Securities Litigation Reform Act , Nasdaq Capital , Annual Report , States Securities , Edgar Online , Evelo Biosciences , Nc Stock Exchange , News , Information , Press Release , Item , Notice , F , Elisting , Dr , Failure , O , Asatisfy , Ontinued , Listing , Transfer , Pril , Zvelo , Eceived , He Evlo Us2997341035 ,